Rise in COVID-19: 63 instances of JN.Up until Sunday, just one variety had been found nationwide, with Goa having the greatest frequency

According to Health Ministry officials on Monday, there have been 63 instances of COVID-19 sub-variant JN.1 identified as of Sunday, with Goa reporting the largest number of cases.

34 instances of the JN.1 variety are reported to be from Goa, nine from Maharashtra, eight from Karnataka, six from Kerala, four from Tamil Nadu, and two from Telangana out of the total cases. They noted that all of the JN.1 subvariant patients had modest symptoms and that there hasn’t been any clustering of cases documented yet.

At the moment, Kerala has the greatest number of COVID-19 cases nationwide, with 4,054 instances now under investigation.

According to statistics from the Health Ministry, “there are 37 COVID-19 cases from Goa, 344 from Karnataka, 3128 from Kerala, and 50 from Maharashtra.”

Dr. Soumya Swaminathan, a former head scientist of the World Health Organization (WHO), has said that JN.1 is an interesting variety and not to be concerned about, thus there is no reason to worry. She advised everyone to exercise care and take the necessary safety precautions.

Dr. Swaminathan, a former Director General of the Indian Council of Medical Research (ICMR), told ANI, “We need to be cautious, but we don’t need to worry because we don’t have any data to suggest that this variant JN.1 is more severe or it’s going to cause more pneumonia, more deaths.”

India According to Dr. NK Arora, head of the SARS-CoV-2 Genomics Consortium (INSACOG), there is currently no need for a second dosage of the vaccine to protect against the subvariant.

“Those who are 60 years of age or older, those who are prone to have comorbidities, and those who use medications that lower immunity, such as cancer patients, should all practice preventive, in my opinion. There is no need for any more dosages; if they have not taken precautions already, they are recommended to do so,” he told ANI.

The head of INSACOG said that although many Omicron subvariants have been identified, none of them have become more severe.

“Every week, you hear about something new that starts in one area and eventually spreads across India. Thankfully, none of the Omicron variations of this virus that we have found—more than 400 subvariants or mutations—have actually been linked to more serious illness or hospitalization, the speaker said.

He went over the main JN.1 symptoms and noted how they are comparable to those of other subvariants.”The lack of ability to distinguish JN.1 from other Omicron subvariants, such as fever, nasal discharge, and cough, results in extremely similar symptoms.” The doctor said that while they often recover in two to five days, there may be occasional diarrhea and severe bodily pains.

JN.1 is now considered to be a variation of interest by the World Health Organization (WHO), different from its parent lineage BA.2.86. The global health organization did, however, stress that, according to available data, the overall danger presented by JN.1 is still low.